NUCC-390
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-111793-100 mg |
| CAS # | 1060524-97-1 |
| Pricing | 100 mg, USD $2250.0 |
| Biological Activity | NUCC-390 is a novel and selective small-molecule CXCR4 receptor agonist. NUCC-390 induces internalization of CXCR4 receptors and acts in an opposite way of AMD3100 (HY-10046)[1][2]. NUCC-390 promotes nerve recovery of function after neurodegeneration in vivo[2]. |
| MWt | 395.54 |
| Formula | C₂₃H₃₃N₅O |